Altris AI
Developing a software (AI platform), designed to improve the diagnostic process in ophthalmology by creating a deep learning trained algorithm for automated detection at early, asymptomatic stages of Glaucoma.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Seed | |
| Total Funding | 000k | ||
| USD | 2021 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Altris AI operates in the healthcare technology sector, specifically focusing on ophthalmology and optometry. The company provides an AI-driven platform that automates the analysis of Optical Coherence Tomography (OCT) scans, identifying 70 different pathologies and biomarkers. This service is designed to assist eye care specialists in making more accurate diagnostic decisions, thereby improving patient outcomes and increasing the efficiency of clinical operations. The platform is compatible with all OCT devices, making it accessible to a wide range of eye care professionals globally. Altris AI's business model includes offering free trials to clinics and optometrists, followed by subscription-based access to their platform. Revenue is generated through these subscriptions, as well as potential partnerships with eye care institutions. The company serves ophthalmologists and optometrists, aiming to elevate diagnostic standards and reduce preventable blindness. Key markets include clinics, hospitals, and private practices in the eye care industry.
Keywords: AI, ophthalmology, optometry, OCT scans, pathology detection, biomarkers, diagnostic accuracy, patient outcomes, healthcare technology, subscription model.